Quad-Cities Investment Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Quad-Cities Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,027	Closed	-$49K	–	651
2019 Q3	$49K	Hold	7,027	–	–	0.04%	339
2019 Q2	$65K	Buy	7,027 +2,000	+40%	+$24.1K	0.06%	288
2019 Q1	$78K	Hold	5,027	–	–	0.07%	253
2018 Q4	$78K	Hold	5,027	–	–	0.08%	236
2018 Q3	$108K	Buy	5,027 +1,000	+25%	+$23.2K	0.1%	210
2018 Q2	$98K	Buy	+4,027	New	+$82.1K	0.09%	222

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Quad-Cities Investment Group's TEVA Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2019, closing a stake of 7,027 shares — an estimated $49K sold.

Quad-Cities Investment Group first reported a position in TEVA in Q2 2018 and held it in 6 quarters. The position peaked at $108K in Q3 2018. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Quad-Cities Investment Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2019 after selling out during the quarter.
Quad-Cities Investment Group sold 7,027 Teva Pharmaceutical Industries Limited shares in Q4 2019, an estimated $49K.
Quad-Cities Investment Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2018 and held it in 6 quarters.
Quad-Cities Investment Group's Teva Pharmaceutical Industries Limited position peaked at $108K in Q3 2018.
437 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.